Literature DB >> 16061707

Neutrophil cell death, activation and bacterial infection in cystic fibrosis.

A P Watt1, J Courtney, J Moore, M Ennis, J S Elborn.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is characterised by chronic endobronchial bacterial infection and neutrophil mediated inflammation. Neutrophil apoptosis is essential for the resolution of inflammation. This study assessed the relationship between levels of neutrophil apoptosis and sputum microbiology in matched clinically stable patients with CF.
METHODS: Sputum was induced from 34 patients (nine with no Gram negative infection, 10 colonised with Pseudomonas aeruginosa, 10 with Burkholderia cenocepacia, and five with other infections). Apoptotic neutrophils measured by flow cytometric Annexin V/propidium iodide staining and morphology were similar in all groups.
RESULTS: Patients infected with P aeruginosa or B cenocepacia had a significantly lower percentage of viable neutrophils in the sputum than those with no Gram negative infection (Kruskal-Wallis p = 0.01, median (interquartile range (IQR)) 14.2% (9.4-21.6), 15.8% (12.3-19.5), and 48.4% (23.0-66.4); p = 0.003 and p = 0.002, respectively). They also had significantly higher levels of secondary necrotic granulocytes in sputum than patients with no Gram negative infection (Kruskal-Wallis p<0.0001, median (IQR) 55.5% (48.4-64.5), 50.4% (44.6-61.9), and 24.8% (14.4-30.5); p<0.0001 and p<0.0001, respectively). Neutrophils (x 10(6)/g sputum) in P aeruginosa infected patients (Kruskal-Wallis p = 0.05, median (IQR) 6.3 (3.5-12.7)) and B cenocepacia infected patients (5.7 (1.5-14.5)) were significantly higher than in the group with no Gram negative infection (0.5 (0.5-4.3), p = 0.03 and 0.04, respectively).
CONCLUSION: These results suggest that cell death and clearance may be altered in patients with CF colonised with P aeruginosa and B cenocepacia compared with those with no Gram negative infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061707      PMCID: PMC1747479          DOI: 10.1136/thx.2004.038240

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  39 in total

1.  A receptor for phosphatidylserine-specific clearance of apoptotic cells.

Authors:  V A Fadok; D L Bratton; D M Rose; A Pearson; R A Ezekewitz; P M Henson
Journal:  Nature       Date:  2000-05-04       Impact factor: 49.962

Review 2.  Granulocyte apoptosis and its role in the resolution and control of lung inflammation.

Authors:  C Haslett
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

3.  Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  K L Tomlin; O P Coll; H Ceri
Journal:  Can J Microbiol       Date:  2001-10       Impact factor: 2.419

4.  Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection.

Authors:  Lynne R Usher; Roderick A Lawson; Ian Geary; Christopher J Taylor; Colin D Bingle; Graham W Taylor; Moira K B Whyte
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

5.  Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis.

Authors:  X Zhang; E Moilanen; H Kankaanranta
Journal:  Eur J Pharmacol       Date:  2001-11-23       Impact factor: 4.432

6.  Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis.

Authors:  R William Vandivier; Valerie A Fadok; Peter R Hoffmann; Donna L Bratton; Churee Penvari; Kevin K Brown; Joseph D Brain; Frank J Accurso; Peter M Henson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

7.  Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.

Authors:  D Dacheux; B Toussaint; M Richard; G Brochier; J Croize; I Attree
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD.

Authors:  Martin G Kelly; Vanessa Brown; S Lorraine Martin; Madeleine Ennis; J Stuart Elborn
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

10.  Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.

Authors:  A L Pukhalsky; N I Kapranov; E A Kalashnikova; G V Shmarina; L A Shabalova; S N Kokarovtseva; D A Pukhalskaya; N J Kashirskaja; O I Simonova
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more
  26 in total

1.  A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum.

Authors:  Katherine B Hisert; W Conrad Liles; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

2.  CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway.

Authors:  Jesmond Dalli; Guglielmo Rosignoli; Richard P G Hayhoe; Aleksander Edelman; Mauro Perretti
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 3.  Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug development.

Authors:  Carl Persson; Lena Uller
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Azithromycin use in patients with cystic fibrosis.

Authors:  N Principi; F Blasi; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-17       Impact factor: 3.267

Review 5.  Resolution of cell-mediated airways diseases.

Authors:  Carl G Persson; Lena Uller
Journal:  Respir Res       Date:  2010-06-11

6.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

7.  Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.

Authors:  Yanping Yang; Arnaud Friggeri; Sami Banerjee; Khalil Bdeir; Douglas B Cines; Gang Liu; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

8.  Glutaredoxin-1 attenuates S-glutathionylation of the death receptor fas and decreases resolution of Pseudomonas aeruginosa pneumonia.

Authors:  Vikas Anathy; Scott W Aesif; Sidra M Hoffman; Jenna L Bement; Amy S Guala; Karolyn G Lahue; Laurie W Leclair; Benjamin T Suratt; Carlyne D Cool; Matthew J Wargo; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

9.  High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine.

Authors:  Gang Liu; Jing Wang; Young-Jun Park; Yuko Tsuruta; Emmanuel F Lorne; Xia Zhao; Edward Abraham
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.

Authors:  Rabindra Tirouvanziam; Yael Gernez; Carol K Conrad; Richard B Moss; Iris Schrijver; Colleen E Dunn; Zoe A Davies; Leonore A Herzenberg; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.